244 related articles for article (PubMed ID: 30806761)
1. Particulate matter 2.5 induced arrhythmogenesis mediated by TRPC3 in human induced pluripotent stem cell-derived cardiomyocytes.
Cai C; Huang J; Lin Y; Miao W; Chen P; Chen X; Wang J; Chen M
Arch Toxicol; 2019 Apr; 93(4):1009-1020. PubMed ID: 30806761
[TBL] [Abstract][Full Text] [Related]
2. Oxygenated polycyclic aromatic hydrocarbons from ambient particulate matter induce electrophysiological instability in cardiomyocytes.
Ju S; Lim L; Jiao HY; Choi S; Jun JY; Ki YJ; Choi DH; Lee JY; Song H
Part Fibre Toxicol; 2020 Jun; 17(1):25. PubMed ID: 32527278
[TBL] [Abstract][Full Text] [Related]
3. Mutation-specific differences in arrhythmias and drug responses in CPVT patients: simultaneous patch clamp and video imaging of iPSC derived cardiomyocytes.
Pölönen RP; Swan H; Aalto-Setälä K
Mol Biol Rep; 2020 Feb; 47(2):1067-1077. PubMed ID: 31786768
[TBL] [Abstract][Full Text] [Related]
4. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
[TBL] [Abstract][Full Text] [Related]
5. Yohimbine Directly Induces Cardiotoxicity on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Gong Y; Yang L; Tang J; Zheng J; Witman N; Jakob P; Tan Y; Liu M; Chen Y; Wang H; Fu W; Wang W
Cardiovasc Toxicol; 2022 Feb; 22(2):141-151. PubMed ID: 34817810
[TBL] [Abstract][Full Text] [Related]
6. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
Yang X; Papoian T
J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of cardiac contractility modulation on human induced pluripotent stem cell-derived cardiomyocytes.
Feaster TK; Casciola M; Narkar A; Blinova K
Physiol Rep; 2021 Nov; 9(21):e15085. PubMed ID: 34729935
[TBL] [Abstract][Full Text] [Related]
8. The electrophysiological effects of cardiac glycosides in human iPSC-derived cardiomyocytes and in guinea pig isolated hearts.
Guo L; Qian JY; Abrams R; Tang HM; Weiser T; Sanders MJ; Kolaja KL
Cell Physiol Biochem; 2011; 27(5):453-62. PubMed ID: 21691062
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Drug Proarrhythmic Potential in Electrically Paced Human Induced Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes Using Multielectrode Array.
Bai S; Pei J; Chen K; Zhao Y; Cao H; Tian L; Ma Y; Dong H
SLAS Discov; 2021 Mar; 26(3):364-372. PubMed ID: 32914673
[TBL] [Abstract][Full Text] [Related]
10. Functional coculture of sympathetic neurons and cardiomyocytes derived from human-induced pluripotent stem cells.
Winbo A; Ramanan S; Eugster E; Jovinge S; Skinner JR; Montgomery JM
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H927-H937. PubMed ID: 32822546
[TBL] [Abstract][Full Text] [Related]
11. The effects of gentamicin and penicillin/streptomycin on the electrophysiology of human induced pluripotent stem cell-derived cardiomyocytes in manual patch clamp and multi-electrode array system.
Hyun SW; Kim BR; Lin D; Hyun SA; Yoon SS; Seo JW
J Pharmacol Toxicol Methods; 2018; 91():1-6. PubMed ID: 29288713
[TBL] [Abstract][Full Text] [Related]
12. Functional and Transcriptional Characterization of Histone Deacetylase Inhibitor-Mediated Cardiac Adverse Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Kopljar I; Gallacher DJ; De Bondt A; Cougnaud L; Vlaminckx E; Van den Wyngaert I; Lu HR
Stem Cells Transl Med; 2016 May; 5(5):602-12. PubMed ID: 27034410
[TBL] [Abstract][Full Text] [Related]
13. Effects of Electrical Stimulation on hiPSC-CM Responses to Classic Ion Channel Blockers.
Wei F; Pourrier M; Strauss DG; Stockbridge N; Pang L
Toxicol Sci; 2020 Apr; 174(2):254-265. PubMed ID: 32040191
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of cardiotoxicity assessment using calcium transient in human induced pluripotent stem cell-derived cardiomyocytes.
Watanabe H; Honda Y; Deguchi J; Yamada T; Bando K
J Toxicol Sci; 2017; 42(4):519-527. PubMed ID: 28717111
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of empagliflozin on excitation-contraction-coupling in human induced pluripotent stem cell cardiomyocytes.
Pabel S; Reetz F; Dybkova N; Shomroni O; Salinas G; Mustroph J; Hammer KP; Hasenfuss G; Hamdani N; Maier LS; Streckfuss-Bömeke K; Sossalla S
J Mol Med (Berl); 2020 Dec; 98(12):1689-1700. PubMed ID: 33034709
[TBL] [Abstract][Full Text] [Related]
16. Recording of multiple ion current components and action potentials in human induced pluripotent stem cell-derived cardiomyocytes via automated patch-clamp.
Mann SA; Heide J; Knott T; Airini R; Epureanu FB; Deftu AF; Deftu AT; Radu BM; Amuzescu B
J Pharmacol Toxicol Methods; 2019; 100():106599. PubMed ID: 31228558
[TBL] [Abstract][Full Text] [Related]
17. Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia.
Sasaki K; Makiyama T; Yoshida Y; Wuriyanghai Y; Kamakura T; Nishiuchi S; Hayano M; Harita T; Yamamoto Y; Kohjitani H; Hirose S; Chen J; Kawamura M; Ohno S; Itoh H; Takeuchi A; Matsuoka S; Miura M; Sumitomo N; Horie M; Yamanaka S; Kimura T
PLoS One; 2016; 11(10):e0164795. PubMed ID: 27764147
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological enhancement of repolarization reserve in human induced pluripotent stem cells derived cardiomyocytes.
Treat JA; Goodrow RJ; Bot CT; Haedo RJ; Cordeiro JM
Biochem Pharmacol; 2019 Nov; 169():113608. PubMed ID: 31465775
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
[TBL] [Abstract][Full Text] [Related]
20. In Utero Particulate Matter Exposure Produces Heart Failure, Electrical Remodeling, and Epigenetic Changes at Adulthood.
Tanwar V; Gorr MW; Velten M; Eichenseer CM; Long VP; Bonilla IM; Shettigar V; Ziolo MT; Davis JP; Baine SH; Carnes CA; Wold LE
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28400369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
